Vijay Kumar Eedunuri
- Molecular Biology
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Oncology
- Co-authors
- Nicholas MitsiadesBin HeSue Anne ChewCristian CoarfaSubapriya RajamanickamJohn ShouChuandong GengYidong Chen
- Topics
- RNA modifications and cancer (4 papers)Prostate Cancer Treatment and Research (4 papers)Ubiquitin and proteasome pathways (3 papers)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Vijay Kumar Eedunuri
12 papers receiving 945 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 689
- Cancer Research 398
- Pulmonary and Respiratory Medicine 363
- Endocrinology, Diabetes and Metabolism 109
- Oncology 106
Countries citing papers authored by Vijay Kumar Eedunuri
This map shows the geographic impact of Vijay Kumar Eedunuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijay Kumar Eedunuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijay Kumar Eedunuri more than expected).
Fields of papers citing papers by Vijay Kumar Eedunuri
This network shows the impact of papers produced by Vijay Kumar Eedunuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijay Kumar Eedunuri. The network helps show where Vijay Kumar Eedunuri may publish in the future.
Co-authorship network of co-authors of Vijay Kumar Eedunuri
This figure shows the co-authorship network connecting the top 25 collaborators of Vijay Kumar Eedunuri. A scholar is included among the top collaborators of Vijay Kumar Eedunuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijay Kumar Eedunuri. Vijay Kumar Eedunuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 271 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 19 | |
| 8 | 68 | |
| 9 | 30 | |
| 10 | 132 | |
| 11 | 181 | |
| 12 | 175 | |
| 13 | The Protein Kinase C (PKC)/Protein Kinase D (PKD)/Steroid Receptor Coactivator (SRC)-3 pathway is an important therapeutic target in Gα-mutant Uveal Melanomas | 1 |
About Vijay Kumar Eedunuri
Vijay Kumar Eedunuri is a scholar working on Cancer Research, Immunology and Allergy and Molecular Biology, having authored 13 papers that have together received 951 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Prostate Cancer Treatment and Research (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (398 citations), Pulmonary and Respiratory Medicine (363 citations) and Molecular Biology (689 citations). Vijay Kumar Eedunuri has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Nicholas Mitsiades, Bin He, Sue Anne Chew, Cristian Coarfa, Subapriya Rajamanickam, John Shou, Chuandong Geng, Yidong Chen, Manjeet K. Rao and Santosh Timilsina. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.